deferoxamine has been researched along with thromboplastin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartlett, SM; O'Rourke, JF; Pugh, CW; Ratcliffe, PJ | 1 |
Bethea, J; Chisolm, GM; Cui, MZ; DiCorleto, PE; Hamilton, TA; Penn, MS; Winokur, AL | 1 |
2 other study(ies) available for deferoxamine and thromboplastin
Article | Year |
---|---|
Identification of hypoxically inducible mRNAs in HeLa cells using differential-display PCR. Role of hypoxia-inducible factor-1.
Topics: Adenylate Kinase; Animals; Cell Hypoxia; Chelating Agents; Deferoxamine; DNA-Binding Proteins; Gene Expression Regulation; Glucose Transporter Type 3; HeLa Cells; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms, Experimental; Mice; Molecular Sequence Data; Monosaccharide Transport Proteins; Nerve Tissue Proteins; Nuclear Proteins; Oxygen; Polymerase Chain Reaction; RNA, Messenger; Thromboplastin; Transcription Factors; Tumor Cells, Cultured | 1996 |
Smooth muscle cell surface tissue factor pathway activation by oxidized low-density lipoprotein requires cellular lipid peroxidation.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Animals; Antioxidants; Aorta; Azoles; Cells, Cultured; Deferoxamine; Humans; Isoindoles; Kinetics; Lipid Peroxidation; Lipoproteins, LDL; Muscle, Smooth, Vascular; Organoselenium Compounds; Rats; Rats, Sprague-Dawley; Thromboplastin; Tin Compounds; Transcription, Genetic | 2000 |